There is an identified need in Australia’s Vaccine Value Chain to boost vaccine development, translation, commercialisation and access. Globally, there are urgent calls for international collaboration in epidemic and pandemic preparedness research from the World Health Organisation, and calls for critical reforms to the R&D ecosystem for infectious diseases from the Wellcome Trust.
Responding to these issues, in May 2024, Biointelect convened the first-of-its-kind Australia’s Vaccine Value Chain Conference©. This event, under the guidance of an expert steering committee, brought together 217 key decision-makers from industry, academia, government, non-profits, and healthcare providers. The aim was to determine key recommendations for addressing gaps and bottlenecks within the Australian ecosystem.
The Outcomes paper was launched in August 2024 to the event attendees. This comprehensive document encapsulates insights and strategies aimed at enhancing the vaccine value chain in Australia and a first response to these international initiatives. It serves as a valuable resource for all stakeholders, providing actionable recommendations to drive innovation, collaboration, and efficiency in vaccine development and distribution. The launch marks a significant milestone in our ongoing efforts to improve public health outcomes through robust and well-coordinated vaccine initiatives. Thank you to all our sponsors, contributors and conference delegates for making this possible.
